Kimia Biosciences (BOM:530313) Dividend Yield %: 0.00% (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
25 GF Score
Price ₹33.30
View Full Analysis

What is Kimia Biosciences Dividend Yield %?

Kimia Biosciences BOM:530313 +0.15% 25 Dividend Yield % is 0.00% as of Jul. 16, 2026. GuruFocus rates BOM:530313 with a GF Score™ of 25/100. Among 514 Drug Manufacturers companies, Kimia Biosciences ranks worse than 194552.33% on this metric.

As of today (2026-07-16), the Trailing Annual Dividend Yield of Kimia Biosciences is 0.00%.

The historical rank and industry rank for Kimia Biosciences's Dividend Yield % or its related term are showing as below:

BOM:530313's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.94
* Ranked among companies with meaningful Dividend Yield % only.

Kimia Biosciences's Dividend Payout Ratio for the six months ended in . 20 was 0.00.

As of today (2026-07-16), the Forward Dividend Yield % of Kimia Biosciences is 0.00%.

Kimia Biosciences's Dividends per Share for the six months ended in . 20 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Kimia Biosciences  (BOM:530313) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Kimia Biosciences Dividend Yield % Related Terms

Kimia Biosciences Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Dividend Yield % Chart

Kimia Biosciences Annual Data
Trend
Dividend Yield %

Kimia Biosciences Semi-Annual Data
Dividend Yield %

BOM:530313 vs ZTS, UTHR: Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Dividend Yield % falls into.


BOM:530313
25GF Score
Kimia Biosciences Ltd BOM:530313
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Kimia Biosciences (BOM:530313) has a Dividend Yield % of 0.00% as of Jul. 16, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Kimia Biosciences and its competitors. According to the industry distribution chart, Kimia Biosciences ranks #999999 out of 514 companies in the Drug Manufacturers industry.
Is Kimia Biosciences' Dividend Yield % too high?
Kimia Biosciences' current Dividend Yield % is 0.00%. Based on the distribution chart, Kimia Biosciences ranks #999999 out of 514 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kimia Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kimia Biosciences ranks #999999 out of 514 companies for Dividend Yield %. This places Kimia Biosciences in the lower half of its industry. The industry median Dividend Yield % is 1.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.94, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Kimia Biosciences and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kimia Biosciences's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Kimia Biosciences' overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current Dividend Yield % is 0.00% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
25GF Score

Get the complete analysis for BOM:530313

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.30
Price